RecruitingNot ApplicableNCT06708143

Temporal Interference for Drug Resistant Epilepsy

Noninvasive Temporal Interference Stimulation for the Treatment of Drug Resistant Epilepsy

Sponsor

Xuanwu Hospital, Beijing

Enrollment

30 participants

Start Date

Nov 30, 2024

Study Type

INTERVENTIONAL

Conditions

Drug Resistant Epilepsy

Summary

This single-center prospective study aims to investigate the treatment efficacy of temporal interference (TI) in drug-resistant epilepsy patients aged 6-60.

Eligibility

Min Age: 6 YearsMax Age: 60 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying Temporal Interference for people with drug resistant epilepsy. The study is currently recruiting participants at 1 location. People eligible for this study include aged 6 Years to 60 Years.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.